港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

维立志博-B

54.600

-3.400-5.86%

成交量：71.19万

成交额：3,927.10万

市值：108.65亿

市盈率：-27.19

高：58.300

开：57.750

低：53.800

收：58.000

52周最高：83.600

52周最低：51.600

股本：1.99亿

香港流通股本：1.53亿

量比：1.74

换手率：0.47%

股息：- -

股息率：- -

每股收益(LYR):-2.008

净资产收益率：--

总资产收益率：--

市净率：94.68

市盈率(LYR):-27.19

市销率: - -

数据加载中...

总览公司新闻资讯公告

26家创新药公司完成新一轮融资！

维立志博-B08月08日遭主力抛售266.0万元

维立志博-B(09887.HK)悉数行使超额配股权

维立志博-B：悉数行使超额配股权，涉及合共552.93万股

医药行业周报：IO2.0赛道进展喜人静待下半年产业催化

创新药还能再买吗？

维立志博-B08月04日主力净流入159.2万元散户资金抛售

一图解码：港股IPO 7月回顾 22家公司递表维立志博上市首日涨超90%

维立志博-B07月31日遭主力抛售1357.8万元

次新股维立志博-B涨超6%，股价突破83港元创上市新高

老虎资讯综合

异动解读 | 维立志博-B股价盘中大涨5.01%，4-1BB双抗平台引发市场关注

异动解读 | 4-1BB双抗概念股热潮延续，维立志博-B盘中大涨5.01%

I-Mab逆势翻盘

阿基米德Biotech

维立志博港股上市：开盘126%暴涨【招投洞策周报7月21日—7月27日投融资概览】

药渡产业洞察

5家创新药公司获超亿元融资！维立志博登陆港交所，小核酸瑞博生物获逾2亿元E轮支持 | 一周融资

上市暴涨90%，华方资本投出了国内TCE领域第一股

维立志博-B午后强势拉升！此前上市首日股价飙涨近92%

老虎资讯综合

异动解读 | 维立志博-B股价盘中大涨5.07%，IPO热度延续助推股价走高

一周IPO观察：维立志博超40倍国配首日近翻倍，歌尔微、天域半导体等递表；设计软件独角兽Figma美股上市在即

融资申购倍数超3000倍，维立志博首日最高涨127%

览富财经网

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/09887/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"维立志博-B","latestPrice":54.6,"timestamp":1763453299006,"preClose":58,"halted":0,"volume":711932,"delay":0,"floatShares":153000000,"shares":199000000,"eps":-2.008042,"marketStatus":"已收盘","change":-3.4,"latestTime":"11-18 16:08:19","open":57.75,"high":58.3,"low":53.8,"amount":39271015,"amplitude":0.077586,"askPrice":54.75,"askSize":400,"bidPrice":54.6,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.858667,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763515800000},"marketStatusCode":5,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":58,"openAndCloseTimeList":[[1763429400000,1763438400000],[1763442000000,1763452800000]],"volumeRatio":1.739406,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":153000000,"roa":"--","roe":"--","lyrEps":-2.008042,"volumeRatio":1.739406,"shares":199000000,"dividePrice":0,"high":58.3,"amplitude":0.077586,"preClose":58,"low":53.8,"week52Low":51.6,"pbRate":"94.68","week52High":83.6,"institutionHeld":0,"latestPrice":54.6,"committee":-0.333333,"eps":-2.008042,"divideRate":0,"volume":711932,"delay":0,"ttmEps":-1.858667,"open":57.75,"prevYearClose":35,"prevWeekClose":59,"prevMonthClose":53.7,"prevQuarterClose":69.95,"fiveDayClose":59.35,"twentyDayClose":65,"sixtyDayClose":70},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1762531200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2025-11-17","current":-29.375891,"percent":0.923077,"low":-50.052922,"twenty":-43.982813,"median":-41.479633,"eighty":-37.985718,"high":-34.030535,"avg":-41.267877,"sd":3.199788,"marketCap":11535724400},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240},{"date":"2025-08-01","current":-42.800562,"twenty":-46.836196,"median":-44.399434,"eighty":-42.800562,"marketCap":13535375000},{"date":"2025-08-08","current":-41.931377,"twenty":-45.734702,"median":-43.894587,"eighty":-42.800562,"marketCap":13293671875},{"date":"2025-08-15","current":-42.360797,"twenty":-44.683717,"median":-42.975881,"eighty":-41.70245,"marketCap":13409689375},{"date":"2025-08-22","current":-41.268557,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"marketCap":13022964375},{"date":"2025-08-29","current":-41.462871,"twenty":-44.683717,"median":-42.745269,"eighty":-41.268557,"marketCap":13146747980},{"date":"2025-09-05","current":-41.718992,"twenty":-44.115151,"median":-41.93996,"eighty":-40.603026,"marketCap":13087080440},{"date":"2025-09-12","current":-41.612383,"twenty":-43.894587,"median":-41.766832,"eighty":-40.253447,"marketCap":13077135850},{"date":"2025-09-19","current":-40.406926,"twenty":-43.894587,"median":-41.814673,"eighty":-40.270938,"marketCap":12689296840},{"date":"2025-09-26","current":-39.940552,"twenty":-43.592616,"median":-41.710721,"eighty":-39.940552,"marketCap":12510294220},{"date":"2025-10-03","current":-46.021818,"twenty":-44.124681,"median":-41.829747,"eighty":-40.190868,"marketCap":14449489270},{"date":"2025-10-10","current":-44.344385,"twenty":-44.480118,"median":-41.935668,"eighty":-40.263942,"marketCap":13902536820},{"date":"2025-10-17","current":-41.267963,"twenty":-44.480118,"median":-42.061577,"eighty":-40.352531,"marketCap":12927967000},{"date":"2025-10-24","current":-37.571928,"twenty":-44.331016,"median":-41.888099,"eighty":-40.263942,"marketCap":11774394560},{"date":"2025-10-31","current":-34.030535,"twenty":-44.258383,"median":-41.766832,"eighty":-39.846145,"marketCap":10680489660},{"date":"2025-11-07","current":-37.063837,"twenty":-44.143742,"median":-41.612383,"eighty":-39.421071,"marketCap":11625225710},{"date":"2025-11-14","current":-37.306884,"twenty":-44.026925,"median":-41.504614,"eighty":-38.171485,"marketCap":11734616200},{"date":"2025-11-17","current":-36.723723,"twenty":-43.982813,"median":-41.479633,"eighty":-37.985718,"marketCap":11535724400}],"updateTime":1763453342216},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09887\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2558508550","title":"26家创新药公司完成新一轮融资！","url":"https://stock-news.laohu8.com/highlight/detail?id=2558508550","media":"药明康德","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558508550?lang=zh_cn&edition=fundamental","pubTime":"2025-08-09 07:17","pubTimestamp":1754695052,"startTime":"0","endTime":"0","summary":"根据药明康德数据库统计，截至2025年7月31日，2025年7月全球生物医药领域共计完成152起融资活动，累计公开披露的融资总额超过了43亿美元。其中，有26家专注于开发创新疗法的公司完成的单笔融资额突破了5000万美元大关。CoRegen：细胞疗法研发公司7月9日，CoRegen宣布完成9339万美元的融资。Nuclidium：放射性治疗和诊断药物研发公司7月10日，Nuclidium宣布成功完成7900万瑞士法郎B轮融资，用于推进铜基放射性药物平台临床开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809072255a6dbb9f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809072255a6dbb9f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","09887","BK1574","BK1161","02592"],"gpt_icon":0},{"id":"2557716524","title":"维立志博-B08月08日遭主力抛售266.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557716524","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557716524?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 16:15","pubTimestamp":1754640934,"startTime":"0","endTime":"0","summary":"08月08日, 维立志博-B股价跌2.83%，报收68.75元，成交金额4917.2万元，换手率0.48%，振幅4.24%，量比0.46。维立志博-B今日主力资金净流出266.0万元，上一交易日主力净流出469.9万元。该股近5个交易日下跌1.71%，主力资金累计净流入223.2万元；近20日主力资金累计净流出45.2万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808173825a6dac125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808173825a6dac125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09887"],"gpt_icon":0},{"id":"2557586428","title":"维立志博-B(09887.HK)悉数行使超额配股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2557586428","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557586428?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 07:52","pubTimestamp":1754524348,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","09887"],"gpt_icon":0},{"id":"2557585220","title":"维立志博-B：悉数行使超额配股权，涉及合共552.93万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2557585220","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557585220?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 07:45","pubTimestamp":1754523930,"startTime":"0","endTime":"0","summary":"格隆汇8月7日丨维立志博-B(09887.HK)发布公告，招股章程所述超额配股权已于2025年8月6日(星期三)由整体协调人(为其本身及代表国际包销商)悉数行使，涉及合共552.93万股股份，占全球发售项下可供认购发售股份总数约15%(经计及发售量调整权获悉数行使，惟于任何超额配股权获行使前)。超额配发股份将由公司按每股35.00港元发行及配发。超额配发股份将用于加快向同意其根据全球发售认购的相关H股延迟交付的承配人交付部分H股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080707465094d45892&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080707465094d45892&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09887"],"gpt_icon":0},{"id":"2557964733","title":"医药行业周报：IO2.0赛道进展喜人 静待下半年产业催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2557964733","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557964733?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 00:00","pubTimestamp":1754323200,"startTime":"0","endTime":"0","summary":"医药板块本周+2.95%，排名1/31，跑赢沪深300 指数，创新药依然是板块重心。市场短期冲高回调，静待下半年创新药产业催化。IO 2.0 赛道进展喜人，下半年继续重点关注。1）基石药业：计划在ESMO 2025 大会公布全球首款PD-1 三抗的临床研究数据。4）中国生物制药：礼新医药与默沙东合作开发LM-299 进展顺利，7 月已完成技术转移，预计三季度将收到3 亿美金技术转移里程碑付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805194354a4768bf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805194354a4768bf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","BK0216","09926","01177","LU1934453819.USD","LU1997245094.SGD","LU1969619763.USD","LU2488822045.USD","06990","LU1997244956.HKD","09887","LU0456842615.SGD","06821","01541","LU1997245177.USD","LU1979443071.USD","688520","02157","02616","09995","688062","688180","01877","688331","603259","09606","LU2495084118.USD","SBHMY","02696","LU2328871848.SGD","02268"],"gpt_icon":0},{"id":"2556807450","title":"创新药还能再买吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2556807450","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556807450?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 17:41","pubTimestamp":1754300474,"startTime":"0","endTime":"0","summary":"另外，部分创新药个股实现翻倍增长。但是，站在当下节点，创新药还能再买吗？其担忧可总结为三点：第一，中国创新药同质化严重，将演变为内卷式竞争。同时，BD交易时，中国创新药资产可能会被低估，从而影响创新药企业的受益。对于上述担忧，我们认为中国创新药市场整体处于高点，但还存在着更多潜力资产。毫无疑问，参与内卷式竞争的创新药企业存在较高的投资风险。尽管如此，诸多创新药企业仍在通过多种方式进行差异化布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804174436a4742b9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804174436a4742b9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","LU0405327494.USD","LU1997245094.SGD","01530","688506","BK0239","LU1969619763.USD","LU1328615791.USD","LU2580892862.HKD","159992","688235","LU1997244956.HKD","LU2148510915.USD","LU0405327148.USD","LU2328871848.SGD","LU2580892789.USD","BK0060","LU2488822045.USD","02142","09926","01877","02696","BK0188","01276","LU1064130708.USD","LU1997245177.USD","LU1655091616.SGD","688180","LU2495084118.USD","09688","BK0012","01672","09887","06996","688520","LU1064131003.USD","BK0183","BK0196","06160","BK0028","600276"],"gpt_icon":0},{"id":"2556709802","title":"维立志博-B08月04日主力净流入159.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2556709802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556709802?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 16:15","pubTimestamp":1754295354,"startTime":"0","endTime":"0","summary":"08月04日, 维立志博-B股价涨2.14%，报收71.50元，成交金额1.2亿元，换手率1.12%，振幅5.71%，量比0.47。维立志博-B今日主力资金净流入159.2万元，上一交易日主力净流出700.3万元。该股近5个交易日下跌2.46%，主力资金累计净流出1519.6万元；近20日主力资金累计净流出109.3万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804165624a6d20415&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804165624a6d20415&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","BK1161"],"gpt_icon":0},{"id":"2556800709","title":"一图解码：港股IPO 7月回顾 22家公司递表 维立志博上市首日涨超90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556800709","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556800709?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 09:35","pubTimestamp":1754271354,"startTime":"0","endTime":"0","summary":"7月港股IPO市场较上月稍显平静。2025年7月，港股IPO市场共有22家公司递交了上市申请，其中包括老乡鸡、星源材质（300568.SZ）、澜起科技（688008.SH）、歌尔微电子、欣旺达（300207.SZ）和云天励飞（688343.SH）等；同时，有9家公司完成敲钟，成功登陆港交所。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202508_1/bc1ee1d5-7dd2-41ac-b729-16cd81c42b79.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202508_1/bc1ee1d5-7dd2-41ac-b729-16cd81c42b79.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/68900e7a230829fb12e1a375","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1161","HSCEI","YANG","BK4614","HSTECH","09887","07226"],"gpt_icon":0},{"id":"2555838257","title":"维立志博-B07月31日遭主力抛售1357.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555838257","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555838257?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 16:15","pubTimestamp":1753949744,"startTime":"0","endTime":"0","summary":"07月31日, 维立志博-B股价跌5.87%，报收72.15元，成交金额1.8亿元，换手率1.65%，振幅10.83%，量比0.00。维立志博-B今日主力资金净流出1357.8万元，上一交易日主力净流出1195.2万元。该股近5个交易日上涨105.86%，主力资金累计净流入431.8万元；近20日主力资金累计净流入431.8万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731170720a46d35b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731170720a46d35b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887"],"gpt_icon":0},{"id":"1189249429","title":"次新股维立志博-B涨超6%，股价突破83港元创上市新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1189249429","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189249429?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 09:57","pubTimestamp":1753840623,"startTime":"0","endTime":"0","summary":"7月30日，次新股$维立志博-B(09887)$涨超6%，股价突破83港元创上市新高。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8373fc8f0693d3cb43ea2979da82ba81","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"次新股维立志博-B涨超6%，股价突破83港元创上市新高","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"1100114192","title":"异动解读 | 维立志博-B股价盘中大涨5.01%，4-1BB双抗平台引发市场关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1100114192","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100114192?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 09:54","pubTimestamp":1753840479,"startTime":"0","endTime":"0","summary":"维立志博-B今日盘中大涨5.01%，引发市场广泛关注。该公司作为一家专注于创新生物技术的企业，近期在4-1BB双抗体平台方面的进展可能是推动股价上涨的主要原因。据悉，维立志博-B的核心产品LBL-024是一种PD-L1 x 4-1BB双特异性抗体，属于第二代免疫肿瘤疗法的差异化技术路线。值得注意的是，维立志博-B在攻克4-1BB靶点的研发壁垒方面取得了突破。随着公司继续推进临床试验并发布更多数据，市场对维立志博-B的关注度可能会进一步提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09887"],"gpt_icon":1},{"id":"1149859553","title":"异动解读 | 4-1BB双抗概念股热潮延续，维立志博-B盘中大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149859553","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149859553?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 09:54","pubTimestamp":1753840478,"startTime":"0","endTime":"0","summary":"7月30日周三盘中，港股上市公司维立志博-B股价出现显著上涨，截至上午9时52分，该股涨幅达到5.01%。维立志博-B是一家专注于创新药物研发的生物科技公司，其核心产品管线包括备受市场关注的4-1BB双抗药物。分析人士认为，维立志博-B今日的股价上涨可能与市场对4-1BB双抗药物持续看好有关。随着更多投资者认识到这一创新疗法的潜力，以及公司在该领域的领先地位，维立志博-B的股价可能会继续受到追捧。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09887"],"gpt_icon":0},{"id":"2555169098","title":"I-Mab逆势翻盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2555169098","media":"阿基米德Biotech","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555169098?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 08:37","pubTimestamp":1753835826,"startTime":"0","endTime":"0","summary":"I-Mab今年以来上涨近150%，但4-1BB双抗的价值还远未释放，知名投行Jefferies对I-Mab给出5美元的目标价，仍有翻倍空间。维立志博拥有一项4-1BB双抗资产，而I-Mab拥有两项4-1BB双抗资产，并且全部在美国开展临床。I-Mab踩准大药方向。攻克毒性难题I-Mab两项4-1BB双抗具有低毒性，得益于精密的分子设计。其实，在天境生物中美业务切割时，康桥资本就已经预见到I-Mab将翻盘，而市场共识直到二代IO、4-1BB双抗价值显现时，才恍然大悟I-Mab翻盘了。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730090954a6c8a029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730090954a6c8a029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","BK1574","BK1583","BK1161","01952","IMAB","ABVX"],"gpt_icon":1},{"id":"2555108068","title":"维立志博港股上市：开盘126%暴涨【招投洞策周报7月21日—7月27日投融资概览】","url":"https://stock-news.laohu8.com/highlight/detail?id=2555108068","media":"药渡产业洞察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555108068?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 13:14","pubTimestamp":1753766096,"startTime":"0","endTime":"0","summary":"一周投融资事件概述据药渡企业洞察统计，大健康领域共披露投融资事件34起，其中18起融资披露了融资金额和币种信息，总规模超63.74亿元人民币。按照金额划分：亿元及以上事件11起，最高金额来自专注于抗体药物研发商南京维立志博生物，宣布港交所IPO，超3000亿资金认购，医学博士凭PD-L1双抗敲钟。按照已披露的融资轮次：早期融资10起，中后期融资8起，战略融资5起，被收购2起，IPO上市3起，股权转让4起。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729144316a4690cef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729144316a4690cef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","HSTECH","07226","09887"],"gpt_icon":1},{"id":"2554777670","title":"5家创新药公司获超亿元融资！维立志博登陆港交所，小核酸瑞博生物获逾2亿元E轮支持 | 一周融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777670","media":"创鉴汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554777670?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 17:32","pubTimestamp":1753695148,"startTime":"0","endTime":"0","summary":"与前几周相比，上周全球创新药领域一级市场融资稍微回暖，超亿美元大额融资增加。此次融资将助力其候选药物研发，预计首个项目将于2026年进入临床。IPO市场，维立志博登陆港交所，募资总额约1.89亿美元。这也是继拨康视云，本月第二家港股上市的创新药公司。此外，在自身免疫疾病方面，维立志博研发了1款双特异性融合蛋白及1款三特异性抗体。核酸领域共发生2起融资。瑞博生物获逾2亿元E轮支持，累计已完成超18亿元多轮融资。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728190802a6c5e01a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728190802a6c5e01a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09887","06978","BK1161"],"gpt_icon":1},{"id":"2554372516","title":"上市暴涨90%，华方资本投出了国内TCE领域第一股","url":"https://stock-news.laohu8.com/highlight/detail?id=2554372516","media":"投中网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554372516?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 14:41","pubTimestamp":1753684875,"startTime":"0","endTime":"0","summary":"来源丨投中网2025年7月25日，华方资本早期孵化企业南京维立志博生物科技股份有限公司在香港交易所主板正式挂牌上市，股票代码为9887.HK。至暗时刻，华方资本再次出手，联合母公司华立集团（原）旗下上市公司昆药集团共同领投了新一轮共计2亿元的投资，帮助维立志博度过了发展中最危急的关头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728145919a4672126&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728145919a4672126&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","600422"],"gpt_icon":1},{"id":"1155536094","title":"维立志博-B午后强势拉升！此前上市首日股价飙涨近92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155536094","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155536094?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 13:30","pubTimestamp":1753680607,"startTime":"0","endTime":"0","summary":"7月28日，$维立志博-B(09887)$午后强势拉升，现涨超6%，此前上市首日股价飙涨近92%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b96f9e7d8090c255d89984c6a78fb415","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"维立志博-B午后强势拉升！此前上市首日股价飙涨近92%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"1103432189","title":"异动解读 | 维立志博-B股价盘中大涨5.07%，IPO热度延续助推股价走高","url":"https://stock-news.laohu8.com/highlight/detail?id=1103432189","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103432189?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 13:22","pubTimestamp":1753680151,"startTime":"0","endTime":"0","summary":"港股新上市公司维立志博-B今日盘中大涨5.07%，延续了其上市以来的强劲表现，引发市场广泛关注。据报道，维立志博上市当天股价一度飙升127%，收盘时仍保持91.7%的涨幅，每股报67.1港元，总市值达129.7亿港元。数据显示，维立志博的融资申购倍数超过3000倍，融资申购额高达3300亿港元，成为7月以来港股IPO中最受追捧的新股。维立志博此次IPO全球发售3686.25万股H股，最终定价为每股35港元，共募集资金12.9亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b96f9e7d8090c255d89984c6a78fb415","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09887"],"gpt_icon":1},{"id":"2554747121","title":"一周IPO观察：维立志博超40倍国配首日近翻倍，歌尔微、天域半导体等递表；设计软件独角兽Figma美股上市在即","url":"https://stock-news.laohu8.com/highlight/detail?id=2554747121","media":"FX168","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554747121?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 11:18","pubTimestamp":1753672717,"startTime":"0","endTime":"0","summary":"截止2025年的第30周，港交所无新股上市，1家上市，1家招股，1家聆讯，9家递表。维立志博-B招股结束并于7月25日上市，募资12.90亿港元，市场申购火热，国配超40倍。7月25日，福建乐摩物联科技向港交所递交招股书，拟香港主板挂牌上市。7月22日，维立志博-B开启招股，并预计于2025年7月25日在港交所挂牌上市，摩根士丹利、中信证券为其联席保荐人","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fx168news.com/article/921974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","FIG","09887"],"gpt_icon":1},{"id":"2554074097","title":"融资申购倍数超3000倍，维立志博首日最高涨127%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554074097","media":"览富财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554074097?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 10:18","pubTimestamp":1753669091,"startTime":"0","endTime":"0","summary":"7月25日，维立志博登陆港交所，股价一度涨127%，收盘涨91.7%，每股报67.1港元，总市值为129.7亿港元。实际上，维立志博在申购期内的火爆程度，已为其上市首日的股价飙升埋下了伏笔。数据显示，维立志博的融资申购倍数超3000倍，融资申购额达到3300亿港元，成为7月以来港股IPO最热新股。维立志博此次IPO全球发售3686.25万股H股，最终每股发售价为35港元，募资总额为12.9亿港元，所得款净额约11.79亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072810181494be5b66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"b96f9e7d8090c255d89984c6a78fb415","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072810181494be5b66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":152,"code":"91000000","status":"200"}]}}